Intellia Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Good afternoon. Welcome to Barclays' Global Healthcare Conference.
My name is Gena Wang. I'm a SMID-cap biotech analyst.
It is my great pleasure to introduce our next presenting company, Intellia. With us today, we have David Lebwohl, Chief Medical Officer. We also have Glenn Goddard, Chief Financial Officer. And Glenn will give us a brief overview with a few slides.
Great. Thank you, Gena. And I'll just start. We picked 3 slides from our corporate deck to start us off; help level set, especially for people that may be newer to Intellia.
So this first slide, I think, is an important one. It's really how we've built the company and really focuses the company strategy in one picture here. So one thing to know about the company is, at its core, (inaudible) platform. And that's based on a set of novel editing tools that we've pulled together and some delivery tools. And from this
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
